#279 - AMA #53: Metabolic health & pharmacologic interventions: SGLT-2 inhibitors, metformin, GLP-1 agonists, and the impact of statins

This episode explores SGLT2 inhibitors' effectiveness in type 2 diabetes, touching on history, benefits, mechanism of action, and risk reductions. Turning the attention to statins, it unravels the connection between these drugs and insulin resistance.